Podcast Episodes
Back to Search
Episode 239: The STAMPEDE trial
Nick James describes the success this practice changing multi arm prostate study with an adaptive design
3 years, 5 months ago
Episode 238: Paper of the month: Biomarkers for neoadjuvant PD(L)1 therapy
Josh Meeks describes his teams Nature Communications paper (including 11 supplementary figures).
3 years, 5 months ago
Episode 237: 2023 AUA Highlights
Season 2 Episode 237
Tom, who failed to invite a guest, quizzes Brian on the new data from the meeting he attended.
3 years, 5 months ago
Episode 236: ODAC for olaparib
Season 2 Episode 236
Jorge A. Garcia, MD, FACP, chairperson of the Oncologic Drugs Advisory Committee (ODAC) for the US Food & Drug Administration, shared insight on the …
3 years, 6 months ago
Episode 235: Danny Heng and the IMDC classification in renal cancer
Season 2 Episode 235
Daniel Heng, MD, MPH, FRCPC, joins us to discuss IMDC classification for renal cell carcinoma and the treatment of patients with favorable risk disea…
3 years, 6 months ago
Episode 234: Amar Kishan, MD, on Neoadjuvant or Adjuvant Radiotherapy for Prostate Cancer
Season 2 Episode 234
In the first part of our Hollywood tour, Amar Kishan, MD, joins us to discuss his recent meta-analysis published in the Journal of Clinical Oncology …
3 years, 6 months ago
Episode 233: Destaques da 14ª reunião internacional brasileira de câncer urológico
Season 2 Episode 233
Karine Trindade e Fernando Maluf dão uma visão geral da reunião e dos avanços na investigação do câncer no Brasil
3 years, 6 months ago
Episode 232: Belzutifan in early and late renal cancer
Season 2 Episode 232
We’re joined by Toni Choueiri, MD, and Brian Shuch, MD, to discuss several studies on the use of belzutifan alone and in combination with other tre…
3 years, 6 months ago
Episode 231: Ursula Vogl, MD in the Rising Star Series
Season 2 Episode 231
Ursula Vogl, MD, discusses her career in the prostate cancer and renal cell cancer fields, as well as recent projects that she has contributed to inc…
3 years, 6 months ago
Episode 230: FGFR Inhibition in NMIBC With Sia Daneshmand
Season 2 Episode 230
Sia Daneshmand, MD, joins the show to review 2 studies on the use of erdafitinib for the treatment of non-muscle invasive bladder cancer, including t…
3 years, 7 months ago